Isocare 1000 mg/g Inhalation Vapour, Liquid

Страна: Велика Британія

мова: англійська

Джерело: VMD (Veterinary Medicines Directorate)

Активний інгредієнт:

Isoflurane

Доступна з:

Animalcare Ltd

Код атс:

QN01AB06

ІПН (Міжнародна Ім'я):

Isoflurane

Фармацевтична форма:

Inhalation vapour, liquid

Тип рецепту:

POM-V - Prescription Only Medicine – Veterinarian

Терапевтична група:

Cats, Chinchilla, Dogs, Ferrets, Gerbil, Guinea Pigs, Hamsters, Horses, Mice, Ornamental Birds, Rats, Reptiles

Терапевтична области:

Neurological Agent general anaesthetic

Статус Авторизація:

Expired

Дата Авторизація:

2016-07-06

Характеристики продукта

Revised October 2017
AN: 01774/2016
Page 1 of 9
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Isocare 1000 mg/g Inhalation Vapour, Liquid;
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each g contains:
Isoflurane 1000 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Inhalation Vapour, Liquid
Clear, colourless, volatile, liquid
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Horses, dogs, cats, ornamental birds, reptiles, rats, mice, hamsters,
chinchillas, gerbils,
guinea pigs and ferrets.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Induction and maintenance of general anaesthesia
4.3
CONTRAINDICATIONS
Do not use in cases of known susceptibility to malignant hyperthermia.
Do not use in cases of known hypersensitivity to the active substance.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
The metabolism of birds, and to an extent small mammals, is affected
more
profoundly by decreases in body temperature, due to high surface area
to body
weight ratio. Drug metabolism in reptiles is slow and highly dependent
upon
environmental temperature.
The ease and rapidity of alteration of the depth of anaesthesia with
isoflurane and its
low metabolism may be considered advantageous for its use in special
groups of
patients such as old or young, and those with impaired hepatic, renal
or cardiac
function.
Revised October 2017
AN: 01774/2016
Page 2 of 9
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
The use of the product in cardiopathic patients should be considered
only after a
benefit/risk assessment by the veterinarian.
It is important to monitor breathing and pulse. Respiratory arrest
should be treated by
assisted ventilation. It is important to maintain free airways and
properly oxygenate
tissues during the maintenance of anaesthesia. In the case of cardiac
arrest, perform a
complete cardio pulmonary resuscitation.
Special precautions to be taken by the person administering the
veterinary medicinal
product to animals
•
Do not breathe the